In recent years, new MCC markers were reported, such as INSM1 (insulinoma-associated protein 1) and SATB2 (special AT-rich sequence-binding protein 2), but the utility of these markers in a routine evaluation of MCC nodal metastases has not yet been investigated [7–10]. This evidence concerns the gene SATB2 and Merkel cell skin cancer.